|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 768.40 EUR | -1.94% |
|
-1.66% | +28.07% |
| 12-04 | KBC Securities Upgrades Argenx to Buy, Boosts PT | MT |
| 12-02 | European Equities Traded in the US as American Depositary Receipts Higher in Tuesday Trading | MT |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | -15.96 | -8.77 | -15.12 | -6.85 | -0.21 | |||||
Return on Total Capital | -21.63 | -10.64 | -16.85 | -7.57 | -0.23 | |||||
Return On Equity % | -43.8 | -19.4 | -26.54 | -8.54 | 17.36 | |||||
Return on Common Equity | -43.8 | -19.4 | -26.54 | -8.54 | 17.36 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | -496.84 | -9.89 | -57.09 | 22.96 | 46.15 | |||||
SG&A Margin | 273.9 | 58.24 | 107.06 | 56.12 | 46.94 | |||||
EBITDA Margin % | -769.18 | -67.74 | -141.31 | -24.97 | -0.73 | |||||
EBITA Margin % | -770.73 | -68.07 | -141.69 | -25.12 | -0.79 | |||||
EBIT Margin % | -770.73 | -68.13 | -164.15 | -33.16 | -0.79 | |||||
Income From Continuing Operations Margin % | -969.9 | -77.28 | -160.9 | -23.26 | 37.05 | |||||
Net Income Margin % | -969.9 | -77.28 | -160.9 | -23.26 | 37.05 | |||||
Net Avail. For Common Margin % | -969.9 | -77.28 | -160.9 | -23.26 | 37.05 | |||||
Normalized Net Income Margin | -599.51 | -46.9 | -104.13 | -15.71 | 1.74 | |||||
Levered Free Cash Flow Margin | -137.17 | -63.3 | -151.93 | -16.21 | -6.38 | |||||
Unlevered Free Cash Flow Margin | -136.97 | -63.25 | -151.74 | -16.17 | -6.32 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.03 | 0.21 | 0.15 | 0.33 | 0.42 | |||||
Fixed Assets Turnover | 6.18 | 38.52 | 27.5 | 65.21 | 67.93 | |||||
Receivables Turnover (Average Receivables) | 3.19 | 35.09 | 3.05 | 3.72 | 3.54 | |||||
Inventory Turnover (Average Inventory) | - | 8.65 | 4.11 | 3.63 | 3.37 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 6.26 | 8.44 | 9.18 | 9.75 | 7.29 | |||||
Quick Ratio | 6.1 | 7.88 | 8.17 | 8.7 | 6.4 | |||||
Operating Cash Flow to Current Liabilities | -1.29 | -2.01 | -2.85 | -0.99 | -0.12 | |||||
Days Sales Outstanding (Average Receivables) | 114.62 | 10.4 | 119.65 | 98.11 | 103.25 | |||||
Days Outstanding Inventory (Average Inventory) | - | 42.21 | 88.89 | 100.63 | 108.49 | |||||
Average Days Payable Outstanding | - | 51.36 | 89.35 | 74.8 | 82.27 | |||||
Cash Conversion Cycle (Average Days) | - | 1.25 | 119.19 | 123.93 | 129.47 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 0.58 | 0.45 | 0.44 | 0.49 | 0.71 | |||||
Total Debt / Total Capital | 0.57 | 0.45 | 0.44 | 0.49 | 0.71 | |||||
LT Debt/Equity | 0.37 | 0.31 | 0.32 | 0.37 | 0.59 | |||||
Long-Term Debt / Total Capital | 0.37 | 0.31 | 0.32 | 0.37 | 0.59 | |||||
Total Liabilities / Total Assets | 26.56 | 11.09 | 10.23 | 9.8 | 11.35 | |||||
EBIT / Interest Expense | -2.39K | -873.54 | -539.03 | -606.98 | -8.61 | |||||
EBITDA / Interest Expense | -2.37K | -860.44 | -461.87 | -451.67 | -5.12 | |||||
(EBITDA - Capex) / Interest Expense | -2.38K | -869.23 | -462.49 | -452.84 | -5.98 | |||||
Total Debt / EBITDA | -0.02 | -0.03 | -0.02 | -0.06 | -3.68 | |||||
Net Debt / EBITDA | 3.88 | 6.56 | 3.51 | 10.1 | 315.1 | |||||
Total Debt / (EBITDA - Capex) | -0.02 | -0.03 | -0.02 | -0.06 | -3.15 | |||||
Net Debt / (EBITDA - Capex) | 3.87 | 6.49 | 3.51 | 10.07 | 269.34 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -33.97 | 752.59 | -16.52 | 187.66 | 77.22 | |||||
Gross Profit, 1 Yr. Growth % | 135.44 | -83.09 | 381.85 | -215.68 | 256.2 | |||||
EBITDA, 1 Yr. Growth % | 134.25 | -25.38 | 74.14 | -49.16 | -94.85 | |||||
EBITA, 1 Yr. Growth % | 133.96 | -25.17 | 73.77 | -49.01 | -94.4 | |||||
EBIT, 1 Yr. Growth % | 133.96 | -25.11 | 101.15 | -41.89 | -95.76 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 224.56 | -32.9 | 73.81 | -58.42 | -382.34 | |||||
Net Income, 1 Yr. Growth % | 224.56 | -32.9 | 73.81 | -58.42 | -382.34 | |||||
Normalized Net Income, 1 Yr. Growth % | 215.44 | -33.84 | 80.29 | -56.6 | -119.62 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 176.02 | -40.34 | 63.24 | -60.45 | -347.62 | |||||
Accounts Receivable, 1 Yr. Growth % | -98.96 | 9.68K | 759.75 | 73.28 | 95.63 | |||||
Inventory, 1 Yr. Growth % | - | 332.93 | 109.35 | 36 | 31.13 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 16.25 | 36.8 | 2.46 | 39.68 | 91.92 | |||||
Total Assets, 1 Yr. Growth % | 29.61 | 25.04 | 9.96 | 44.93 | 36.55 | |||||
Tangible Book Value, 1 Yr. Growth % | 21.51 | 56.8 | 11.69 | 50.53 | 33.85 | |||||
Common Equity, 1 Yr. Growth % | 29.85 | 51.38 | 11.03 | 45.63 | 34.19 | |||||
Cash From Operations, 1 Yr. Growth % | -357.35 | 52.29 | 42.19 | -51.28 | -80.31 | |||||
Capital Expenditures, 1 Yr. Growth % | -40.84 | 239.23 | -76.9 | -2.99 | 121.8 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 381.89 | 341.32 | 100.38 | -69.31 | -30.26 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 383.22 | 341.72 | 100.28 | -69.34 | -30.75 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 36.59 | 138.58 | 166.79 | 54.97 | 125.78 | |||||
Gross Profit, 2 Yr. CAGR % | 123.22 | -36.1 | -9.72 | 136.09 | 102.99 | |||||
EBITDA, 2 Yr. CAGR % | 127.04 | 33.95 | 13.99 | -5.91 | -83.82 | |||||
EBITA, 2 Yr. CAGR % | 126.61 | 34.05 | 14.03 | -5.87 | -83.1 | |||||
EBIT, 2 Yr. CAGR % | 126.61 | 34.11 | 22.73 | 8.11 | -84.3 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 181.72 | 50.1 | 7.99 | -14.99 | 8.35 | |||||
Net Income, 2 Yr. CAGR % | 181.72 | 50.1 | 7.99 | -14.99 | 8.35 | |||||
Normalized Net Income, 2 Yr. CAGR % | 177.01 | 47.08 | 10.47 | -11.54 | -70.82 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 141.68 | 30.52 | -1.32 | -19.65 | -1.04 | |||||
Accounts Receivable, 2 Yr. CAGR % | 4.57 | 5.17 | 2.8K | 285.97 | 84.11 | |||||
Inventory, 2 Yr. CAGR % | - | - | 201.06 | 68.73 | 33.54 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 239.44 | 31.41 | 18.39 | 19.63 | 63.73 | |||||
Total Assets, 2 Yr. CAGR % | 79.21 | 33.05 | 17.26 | 26.24 | 40.67 | |||||
Tangible Book Value, 2 Yr. CAGR % | 51.03 | 44.26 | 32.34 | 29.67 | 41.95 | |||||
Common Equity, 2 Yr. CAGR % | 59.19 | 46.52 | 29.64 | 27.16 | 39.79 | |||||
Cash From Operations, 2 Yr. CAGR % | 153.63 | 100.05 | 47.15 | -16.77 | -69.03 | |||||
Capital Expenditures, 2 Yr. CAGR % | 23.52 | 42.03 | -11.47 | -52.66 | 46.69 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 137.99 | 259.56 | 197.38 | -21.58 | -53.74 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 137.82 | 259.93 | 197.44 | -21.63 | -53.92 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 9.75 | 151.41 | 68.12 | 173.57 | 62.05 | |||||
Gross Profit, 3 Yr. CAGR % | 195.65 | -5.46 | 25.31 | -1.94 | 170.78 | |||||
EBITDA, 3 Yr. CAGR % | 165.13 | 56.96 | 46.19 | -12.91 | -64.27 | |||||
EBITA, 3 Yr. CAGR % | 163.66 | 56.91 | 46.16 | -12.8 | -63.25 | |||||
EBIT, 3 Yr. CAGR % | 163.66 | 56.95 | 53.51 | -4.34 | -63.26 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 166.08 | 75.3 | 57.62 | -21.44 | 26.84 | |||||
Net Income, 3 Yr. CAGR % | 166.08 | 75.3 | 57.62 | -21.44 | 26.84 | |||||
Normalized Net Income, 3 Yr. CAGR % | 163.59 | 72.28 | 58.87 | -19.09 | -46.45 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 116.94 | 52.19 | 40.62 | -27.24 | 16.93 | |||||
Accounts Receivable, 3 Yr. CAGR % | -34.82 | 386.7 | 111.86 | 1.03K | 207.74 | |||||
Inventory, 3 Yr. CAGR % | - | - | - | 131 | 55.13 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 141.27 | 156.66 | 20.95 | 25.1 | 40.04 | |||||
Total Assets, 3 Yr. CAGR % | 71.09 | 63.02 | 24.86 | 25.84 | 29.59 | |||||
Tangible Book Value, 3 Yr. CAGR % | 52.69 | 56.85 | 32.46 | 38.15 | 31.05 | |||||
Common Equity, 3 Yr. CAGR % | 58.15 | 60.56 | 33.58 | 34.77 | 29.46 | |||||
Cash From Operations, 3 Yr. CAGR % | 111.62 | 114.8 | 78.53 | 1.8 | -48.53 | |||||
Capital Expenditures, 3 Yr. CAGR % | 40.11 | 72.37 | -22.47 | -8.73 | -20.78 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 123.49 | 181.32 | 195.89 | 39.49 | -24.59 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 123.38 | 181.24 | 196.04 | 39.46 | -24.8 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 40.52 | 93.44 | 58.5 | 108.35 | 89.17 | |||||
Gross Profit, 5 Yr. CAGR % | 90.92 | 26.11 | 86.35 | 37.11 | 51.98 | |||||
EBITDA, 5 Yr. CAGR % | 93.62 | 71.69 | 91.73 | 28.64 | -39.38 | |||||
EBITA, 5 Yr. CAGR % | 93.22 | 71.33 | 91.12 | 28.63 | -38.33 | |||||
EBIT, 5 Yr. CAGR % | 93.22 | 71.36 | 96.82 | 35.98 | -38.33 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 103.08 | 75.81 | 88.26 | 31.99 | 35.67 | |||||
Net Income, 5 Yr. CAGR % | 103.08 | 75.81 | 88.26 | 31.99 | 35.67 | |||||
Normalized Net Income, 5 Yr. CAGR % | 102.54 | 74.75 | 88.93 | 33.45 | -19.34 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 64.29 | 43.99 | 60.65 | 18.55 | 22.19 | |||||
Accounts Receivable, 5 Yr. CAGR % | -20.11 | 85.67 | 205.73 | 346.12 | 100.29 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 107.13 | 78.63 | 86.35 | 90.21 | 36.52 | |||||
Total Assets, 5 Yr. CAGR % | 109.56 | 88.33 | 51.22 | 48.01 | 30.96 | |||||
Tangible Book Value, 5 Yr. CAGR % | 101.17 | 100.98 | 48.24 | 46.18 | 36.18 | |||||
Common Equity, 5 Yr. CAGR % | 105.45 | 103.8 | 50.15 | 47.09 | 36.03 | |||||
Cash From Operations, 5 Yr. CAGR % | 90.25 | 118.97 | 85.71 | 47.84 | -11.41 | |||||
Capital Expenditures, 5 Yr. CAGR % | 28.2 | 30.55 | 17.82 | 3.38 | 0.06 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 57.51 | 97.59 | 147.86 | 69.73 | 40.85 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 57.46 | 97.56 | 147.8 | 69.66 | 40.68 |
- Stock Market
- Equities
- ARGX Stock
- Financials argenx SE
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















